This review is intended as a practical guide for the use of sacubitril/valsartan in patients with heart failure. It includes extensive commentary from Professor Andrew Sindone on use of sacubitril/valsartan in the clinical
setting. It also summarises recently published literature highlighting the key clinical outcomes
of cardiovascular death, 30-day hospital readmission and quality of life in patients treated
with sacubitril/valsartan.
Please login below to download this issue (PDF)